Ann: Chief Executive Officer and Managing Director Appointment, page-30

I am a long term holder of both KZA and ANP although I only recently bought back into ANP. I'm happy holding both. For those here who say that Kazia's drug, Paxsalisib has failed, you might be in for a surprise. The one failing of James Garner and the board at Kazia, in my opinion, was capital management. They tend to let the kitty run down too far and then put in place a funding scheme where the funder was happy to dump their shares onto market (NASDAQ). This was part of the reason why shareholders did not support the last intensive scheme proposal for James Garner, which was withdrawn prior to the AGM. That may have contributed to his decision to jump ship as he seems to have taken a lower pay to join ANP.